Biologic Therapies Summit X and Vasculitis online series
Infections, COVID-19, Co-Morbidities with IMIDS
Release date: July 13, 2023
Expiration date: July 12, 2025
Estimated Time of Completion: 2 hours
Session Agenda:
Immunizations in the immunocompromised
Kevin Winthrop, MD, MPH, Oregon Health & Science University
Optimal management of COVID-19 in the immunocompromised
Cassandra Calabrese, DO, Cleveland Clinic
Long COVID
Leonard Calabrese, DO, Cleveland Clinic
Current status of COVID vaccinology in the compromised host
Alfred Kim, MD, PhD, St. Louis
Description
Watch Biologic Therapies Summit X and Vasculitis Online Series, on-demand, complimentary webcasts that brings together world leaders in immune-based therapies to address cutting-edge topics in immunology and rheumatology. Education focuses on vasculitis, including key issues in the differential diagnosis of vasculitis, CNS vasculitis, ANCA-associated vasculitis, and organ-specific issues in vasculitis. In addition, the online series features talks on CAR T-cell therapy, irAEs, precision medicine and the next generation of JAK inhibitors for IMIDs, and advances in complement biology and therapy. A deep dive into rheumatoid arthritis, AS, PsA and SpA, infections, COVID-19, co-morbidities with IMIDs, including ILD and cardiovascular risk in immune-mediated diseases, and lupus. Lastly, the CE-certified webcasts address pain management and the exploration of the social and scientific fundamentals of pain.
Disclosures
Cassandra Calabrese, DO | |
Astra Zeneca, Lilly |
Consulting |
Sanofi-Regeneron |
Consulting |
Leonard Calabrese, DO | |
Astra Zeneca, BMS |
Teaching and Speaking |
Novartis, Regeneron, Sanofi Aventis |
Consulting |
Genentech/Roche |
Consulting |
Abbvie Pharmaceuticals, Janssen, UCB |
Consulting |
M. Elaine Husni, MD, MPH | |
Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co, Genzyme/Sanofi, Janssen, Lilly, Regeneron |
Consulting |
Celgene Corporation, Pfizer, Inc. |
Advisor or review panel participant |
Genenetch, UCB, Inc. |
Consulting |
Novartis Pharmaceuticals |
Consulting |
WebMD |
Consulting |
Alfred Hyoungju Kim, MD | |
Aurinia Pharmaceuticals, Exagen Diagnostics, GlaxoSmithKline |
Consulting |
Alexion, ANI Pharmaceuticals, Astrazeneca Pharmaceuticals, Pfizer, Inc. |
Consulting |
Foghorn Therapeutics |
Research: PI on investigator-initiated study |
UpToDate, Inc. |
Independent Contractor: Co-author on a section on COVID and immunosuppression |
Kypha |
Consulting |
Elizabeth Kirchner, DNP | |
Janssen Pharmaceuticals, Inc. |
Consulting |
RhAPP |
Teaching and Speaking |
Boehringer Ingelheim, Horizon Pharma, UCB |
Advisor or review panel participant |
Carol Langford, MD | |
Astrazeneca Pharmaceuticals |
Other activities from which remuneration is received or expected: Non-paid consultant for research Clinical trial funding support - this has ended |
Bristol-Myers Squibb Co. |
Other activities from which remuneration is received or expected: Clinical trial funding support Non- paid consultant for research |
Chemocentryx, GlaxoSmithKline |
Other activities from which remuneration is received or expected: Clinical trial funding support |
Abbvie Pharmaceuticals |
Other activities from which remuneration is received or expected: Non- paid consultant for research |
Amanda Mixon, PA-C | |
Abbvie Pharmaceuticals |
Consulting |
Eli Lilly, Janssen Pharmaceuticals, Inc |
Advisor or review panel participant |
Amgen |
Teaching and Speaking |
Astrazeneca Pharmaceuticals, RhAPP, Sanofi |
Advisor or review panel participant |
UCB, Inc. |
Consulting |
Kevin Winthrop, MD | |
Abbvie Pharmaceuticals, Astra Zeneca, Galapagos, Genentech/Roche, Gilead Sciences, Inc, GSK, Lilly, Novartis, Regeneron, Sanofi, UCB |
Consulting |
Bristol-Myers Squibb Co., Pfizer |
Consulting |
Abbott Laboratories, Cellestis |
Advisor or review panel participant |
Oxford Immunotech |
Other activities from which remuneration is received or expected: research grant |
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this live activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this enduring activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s R.J Fasenmyer Center for Clinical Immunology.